Topical Hyaluronic Acid (HA) – Adult Non-Prescription Skincare Guide

Disclaimer

This guide provides general information for adults (18+) only on the non-prescription, cosmetic-class use of topical hyaluronic acid (HA) ≤ 2%. 1 2

It does not cover diagnosis or treatment of any skin disease and is not a substitute for advice from a GP, dermatologist, or pharmacist. 1 13 15

It excludes children, teenagers, pregnancy, breastfeeding, prescription medicines and Schedule 4 injectable products. 1 2

Always read the label, follow directions for use and seek medical care for persistent, painful, rapidly spreading or systemically associated skin problems. 1 13 15

This document is general information only and does not constitute legal advice or a regulatory determination; clinics should seek specific legal or regulatory advice for borderline products, complex advertising campaigns or enforcement matters.

1. Purpose

This document sets out guidance on safe, evidence-based use of topical hyaluronic acid (HA) and its salts (e.g. sodium hyaluronate) at concentrations ≤ 2% for adult cosmetic skincare in Australia. 1 3

The aim is to support hydration, barrier support and cosmetic fine-line softening while remaining within the cosmetic category under Australian law. 1 2 7

It is intended to be consistent with current TGA cosmetic vs therapeutic guidance, AICIS chemical-introduction rules, AHPRA advertising standards and Australian Consumer Law (ACCC), but does not replace those instruments. 1 2 3 5 6 7 8

2. Scope & Applicability

This guide applies to topical, non-prescription cosmetic products such as serums, creams, gels, lotions and masks containing hyaluronic acid or sodium hyaluronate at ≤ 2% intended for hydration, comfort and improvement in the appearance of skin texture. 1 3 10 16

It is intended for use in adult community settings and cosmetic clinics where medical practitioners or dermal staff give non-therapeutic skincare advice. 2 5 6

It does not apply to injectable hyaluronic acid dermal fillers, Schedule 4 medicines, compounded prescription formulations or devices. 1 2

It also does not apply where products or marketing make therapeutic claims such as "treats eczema", "treats dermatitis" or "heals scars", which may trigger TGA therapeutic regulation. 1 2 7 8

3. Legal & Regulatory Framework (Australia)

3.1 TGA – Cosmetic vs Therapeutic Goods

The TGA determines whether a product is a cosmetic or therapeutic good based on its ingredients, claims and overall presentation. 1 2

Products that only claim to cleanse, perfume, change appearance or maintain skin in good condition are usually cosmetics, provided they make no disease or treatment claims. 1

If a hyaluronic acid product claims to treat or prevent a disease, or uses actives in therapeutic strengths, it may be a therapeutic good and require ARTG inclusion and full regulatory oversight. 1 2

3.2 AICIS – Cosmetic Ingredient Regulation

Most skincare ingredients, including hyaluronic acid, are regulated as industrial chemicals under AICIS. 3 4

Importers and manufacturers must categorise their introduction and comply with the Industrial Chemicals Act 2019 and Industrial Chemicals (General) Rules 2019. 3 4

Hyaluronic acid used in typical cosmetic concentrations in leave-on products is generally introduced within cosmetic categories, provided volume, hazard and exposure criteria are met. 3 4

3.3 AHPRA – Advertising of Regulated Health Services

Clinics run by registered health practitioners must comply with AHPRA advertising guidelines. 5

Claims must not be false, misleading, deceptive or create unreasonable expectations of treatment success or permanent change. 5 6

Cosmetic-procedure advertising guidance also flags risks of overreliance on before-and-after photos, testimonials and "miracle" language in aesthetics. 6

3.4 ACCC – Australian Consumer Law

Under the Australian Consumer Law (ACL), all skincare advertising must avoid misleading or deceptive conduct and must be substantiated. 7 8

Claims such as "clinically proven" or "dermatologist recommended" require adequate evidence and must not exaggerate benefits beyond what the data supports. 7 8

These requirements apply equally to website copy, social media posts, clinic materials and influencer arrangements. 7 8

4. Mechanism of Action (Skin Science)

Hyaluronic acid is a glycosaminoglycan naturally present in human dermis and extracellular matrix, with an exceptional capacity to bind large volumes of water. 9 10

Its hygroscopic properties underpin its role as a key molecule in skin moisture and turgor, with natural levels declining with age and photodamage. 9 10

When used topically, hyaluronic acid and sodium hyaluronate form a hydrating film on the stratum corneum that reduces transepidermal water loss (TEWL) and smooths skin micro-relief. 9 10 12

Different molecular weights provide different functional profiles: high-molecular-weight hyaluronic acid gives surface hydration and soothing, while lower molecular weights can penetrate further for more pronounced plumping and elasticity effects. 9 10 16

Clinical studies of topical hyaluronic acid formulations show improved corneometry readings, elasticity indices and visible reduction in fine lines after regular use over several weeks. 10 11

These benefits are cosmetic and reversible; they do not equate to structural correction of disease processes or scarring. 9 11

5. Indications & Patient Selection

Topical hyaluronic acid ≤ 2% is suitable for adults (≥18 years) seeking improved comfort, hydration and smoother skin appearance without a medical diagnosis. 11 13

It can be used across all Fitzpatrick skin types, including dry, sensitive and mature skin, when the epidermis is intact and not actively inflamed or infected. 13 15

It should be used with caution or avoided on broken, weeping, ulcerated, infected or severely inflamed skin, where medical review is more appropriate. 13 15

Patients with a history of contact allergy to skincare ingredients should patch-test new hyaluronic acid products on a small area for several days before full-face use. 13 14

This guide intentionally excludes pregnancy, breastfeeding and paediatric populations; these cohorts should follow individualised medical advice. 1 13

6. Formulations & Concentrations

Commercial hyaluronic acid products frequently use blends of molecular weights and derivatives to balance feel and efficacy. 9 10 16

High-molecular-weight hyaluronic acid predominately hydrates the skin surface, while low-molecular-weight and oligo-hyaluronic acid can penetrate further but may be more reactive if overused. 9 10 16

Sodium hyaluronate is the most common cosmetic form due to better stability and solubility compared with native hyaluronic acid. 10 16

Leave-on facial products typically contain hyaluronic acid or sodium hyaluronate in the range of approximately 0.1–2%, with higher concentrations often giving more tackiness rather than proportionally greater clinical benefit. 10 11 16

Combining hyaluronic acid with other ingredients such as ceramides, niacinamide, panthenol or antioxidants can further support barrier function and cosmetic outcome. 12 16 17

7. Application Protocol (Adult, Non-Prescription Use)

A sensible general routine for adults using hyaluronic acid as part of non-prescription skincare is:

Cleanse: Use a non-soap, low-irritant cleanser to avoid stripping barrier lipids and exacerbating dryness. 13 14 15 Rinse with lukewarm water and gently pat skin dry, leaving a slight film of surface moisture. 13 15

Apply hyaluronic acid: Apply a thin layer of hyaluronic acid serum, gel or lotion (for example 1–2 pumps or a few drops) to the face and neck, avoiding the eyelid margin and mucous membranes. 10 11 Application to slightly damp skin helps hyaluronic acid bind environmental and stratum-corneum water, reducing the chance of a tight sensation. 10 12

Seal with moisturiser: Follow promptly with a moisturiser or barrier cream containing emollients and/or occlusives to lock in hydration and support barrier repair. 12 13 14 For very dry or eczematous-prone skin under medical care, hyaluronic acid is adjunctive to — not a replacement for — regular emollient use. 13 14 15

Sun protection: Use broad-spectrum SPF 50+ on exposed areas daily as part of routine sun protection in Australia. 6 15 Hyaluronic acid itself is not photosensitising, but hydrated skin still needs UV protection to reduce photoageing and skin cancer risk. 6 9

Layering with actives: Hyaluronic acid generally layers well with retinoids, vitamin C and niacinamide; using hyaluronic acid before or after actives can help offset dryness and improve cosmetic tolerance. 10 13 17 In sensitive skin, it is prudent to avoid stacking hyaluronic acid directly over strong acids or highly alcoholic toners in one step, as cumulative irritation may occur. 13 17

8. Expected Outcomes

Most users notice improved comfort and softness within minutes to days, reflecting rapid hydration effects on the stratum corneum. 10 11

Over 1–2 weeks, the skin often appears smoother and more supple as surface fine lines from dryness become less apparent. 10 11 17

Clinical data show that consistent use of hyaluronic acid serums over 4–8 weeks can significantly increase skin hydration measures and improve elasticity and fine-line appearance compared with baseline. 10 11

Outcomes are maintenance-dependent: if hyaluronic acid-containing products are stopped, measures of hydration and texture gradually return toward pre-treatment levels. 9 11

9. Adverse Effects & Management

Topical hyaluronic acid is generally well tolerated, with most adverse events being mild and related to vehicle excipients, preservatives or fragrance rather than hyaluronic acid itself. 13 14 17

Common minor complaints include a temporary feeling of tightness or tackiness if hyaluronic acid is applied neat and allowed to dry without a moisturiser on top. 10 14

Management usually involves applying hyaluronic acid over damp skin, reducing the amount used and ensuring a moisturiser is applied promptly over the top. 12 14

In barrier-impaired or highly sensitive skin, hyaluronic acid products formulated with fragrance, alcohol or multiple actives can trigger stinging or erythema. 13 14 17

Rarely, patients may develop irritant or allergic contact dermatitis to a hyaluronic acid formulation, presenting with persistent redness, itch, burning or scaling. 13 14

In such cases, the product should be stopped, recorded as a suspected adverse reaction and, if symptoms persist, the patient should be referred to their GP or dermatologist. 13 15

Hyaluronic acid does not increase sun sensitivity, but should always be paired with appropriate sun protection for cosmetic and health reasons in the Australian environment. 6 9

10. Storage & Quality Considerations

Hyaluronic acid products should be stored according to the manufacturer’s label, commonly below 25–30°C and away from direct sunlight or heat sources. 7 8

Exposure to heat or contamination can cause changes in viscosity, colour, odour or performance, warranting disposal of the product. 7 8

Clinics should maintain a batch and expiry log, use first-in-first-out (FIFO) rotation, and avoid decanting or refilling containers unless this is done under controlled, hygienic and correctly labelled conditions. 3 4 5

11. Advertising & Labelling – Safe Claim Framework

For a non-prescription hyaluronic acid cosmetic, acceptable appearance-based claims (assuming internal evidence is held) include phrases such as: "Hydrates the skin and improves the look of dryness" or "Helps skin feel smoother and look more supple with regular use." 1 7 8

Such wording stays within cosmetic territory by describing appearance and sensory benefits, not treatment of disease. 1 2 7

High-risk or likely unacceptable claims for a non-therapeutic cosmetic include: "Treats eczema", "heals dermatitis", "regenerates damaged tissue" or "repairs joint cartilage." 1 2 7 8

Under AHPRA and the ACL, advertising must not mislead, must not guarantee outcomes and must not imply that a cosmetic-class hyaluronic acid product is equivalent to a therapeutic intervention. 5 6 7 8

Minimum labelling should include wording such as "External use only", "Avoid contact with eyes and broken skin", and "Discontinue use and seek advice if irritation persists." 7 13 18

12. Roles & Responsibilities (Clinic Context)

Medical Director / Responsible Practitioner: The Medical Director approves the clinic’s hyaluronic acid product range and reviews its alignment with TGA/AICIS/ACL boundaries and evidence. 1 3 5 7

They also review documented adverse reactions and update guidance or product selections when safety or regulatory issues emerge. 5 13 15

Clinic Manager / Compliance Lead: The Clinic Manager ensures suppliers are AICIS-compliant, maintains the product register and SDS library, and oversees batch, expiry and stock rotation processes. 3 4 5

They also coordinate implementation of advertising standards across website, social media and in-clinic collateral. 5 7 8

Therapists / Clinical Staff: Staff provide evidence-aligned, non-therapeutic counselling on hyaluronic acid use and general skincare, staying within scope and avoiding disease-treatment advice. 5 13

They document product recommendations and any reported adverse effects in the clinical record and escalate concerns appropriately. 13 15

13. Audit & Review

A simple governance structure for hyaluronic acid and similar cosmetic-class skincare might include:

Annual: Review product list, ingredients, claims, supplier status and regulatory changes relevant to cosmetics. 1 3 5

Quarterly: Check batch records, expiry dates, SDS currency and a sample of clinical records for documentation quality. 3 4 5

Biennial (every 24 months): Provide staff education on cosmetic vs therapeutic boundaries, AHPRA/ACL advertising rules and updated evidence on topical hyaluronic acid and moisturisers. 2 5 7 13 14

14. Frequently Asked Questions

Q1. Is hyaluronic acid safe for most adults?

Topical hyaluronic acid is widely used and is generally considered low-risk when used in cosmetic formulations as directed. 9 10 13

Most reactions are due to fragrances, preservatives or other components rather than hyaluronic acid itself, so patch-testing new products on a small area is sensible, especially in sensitive skin. 13 14

Q2. Will hyaluronic acid fix my eczema or dermatitis?

No. Hyaluronic acid is a cosmetic hydrator, not a treatment for eczema, dermatitis or psoriasis. 1 13 15

People with chronic inflammatory skin disease should follow their doctor’s plan, using medical emollients and treatments as prescribed, and only adding hyaluronic acid products if this fits with that plan. 13 15

Q3. How often should I use a hyaluronic acid serum?

Most adults can use hyaluronic acid once or twice daily as part of a regular skincare routine. 10 11 13

Evidence suggests that steady, ongoing use matters more than very frequent reapplication on one day, with improvements in hydration and texture seen over weeks. 10 11

Q4. Do I still need a moisturiser if I use hyaluronic acid?

Yes. Hyaluronic acid draws and holds water, but a separate moisturiser provides lipids and occlusives that seal this water into the skin and repair the barrier. 12 13 14

Guidelines for xerosis emphasise frequent moisturiser use as the backbone of care, with humectant ingredients such as hyaluronic acid acting as helpful adjuncts. 13 14 15

Q5. Can I use hyaluronic acid with retinol or vitamin C?

In most adults, yes: hyaluronic acid is commonly combined with retinoids and vitamin C to offset dryness and improve comfort. 10 13 17

If irritation occurs, simplifying the regimen and re-introducing actives slowly while maintaining a good moisturiser base is usually more effective than adding more products. 13 14

Q6. My skin feels tighter after hyaluronic acid – is that bad?

Not necessarily. A tight feeling often reflects hyaluronic acid drying on the surface without enough moisture or emollient on top. 10 12 14

Applying hyaluronic acid on damp skin and sealing quickly with moisturiser usually removes this issue; if redness, burning or itch persists, the product should be stopped and, if needed, assessed medically. 13 14

Q7. Is a higher percentage (2%) always better than 0.5–1%?

No. Above a certain concentration, higher hyaluronic acid levels mainly increase stickiness rather than delivering proportionally better cosmetic results. 10 11 16

Well-designed studies show hydration and fine-line improvements at modest hyaluronic acid concentrations in balanced formulations, so formulation quality and routine matter more than chasing maximum percentage. 10 11 16

Q8. Can hyaluronic acid be used after laser or chemical peels?

Often yes, once the skin surface is intact and not weeping, as part of post-procedure care guided by the treating practitioner. 11 13 15

In post-procedure regimens, bland emollients and strict sun protection remain primary, with hyaluronic acid added for comfort and cosmetic hydration where tolerated. 11 13 15

Q9. Does hyaluronic acid increase sun sensitivity?

No. Hyaluronic acid is not an exfoliant and does not increase photosensitivity. 9 10

However, Australian guidelines emphasise daily broad-spectrum SPF 50+, hats and shade as standard because UV radiation remains the dominant driver of photoageing and skin cancer regardless of skincare use. 6 15

Q10. Do more expensive hyaluronic acid serums work better?

Not automatically. Dermatology and consumer resources consistently note that higher price does not guarantee better clinical performance. 14 18 19

Simple, fragrance-reduced, well-formulated hyaluronic acid products from reputable brands, used correctly and consistently, can perform as well or better than very expensive alternatives. 13 14 18 19

Sources

  1. Therapeutic Goods Administration (TGA) 2024, Determining if your product is a cosmetic or therapeutic good, Australian Government. Available at: https://www.tga.gov.au/resources/guidance/determining-if-your-product-cosmetic-or-therapeutic-good
  2. Therapeutic Goods Administration (TGA) 2024, Cosmetics and therapeutic goods: Guidance for advertisers and suppliers, Australian Government. Available at: https://www.tga.gov.au/sites/default/files/2024-06/cosmetics-therapeutic-goods-guidance-for-advertisers-suppliers.pdf
  3. Australian Industrial Chemicals Introduction Scheme (AICIS) 2025, Personal care, skincare, make-up and other cosmetic products, Australian Government. Available at: https://www.industrialchemicals.gov.au/cosmetics-and-soap/personal-care-skincare-make-and-other-cosmetic-products
  4. Australian Industrial Chemicals Introduction Scheme (AICIS) 2024, Categorisation of chemicals in cosmetics, Australian Government. Available at: https://www.industrialchemicals.gov.au/help-and-guides/extra-resources-help-you-categorise-your-introduction/categorisation-chemicals-cosmetics
  5. Ahpra 2024, Guidelines for advertising a regulated health service, Australian Health Practitioner Regulation Agency. Available at: https://www.ahpra.gov.au/Resources/Advertising-hub/Advertising-guidelines-and-other-guidance/Advertising-guidelines.aspx
  6. Ahpra & Medical Board of Australia 2023, Guidelines for registered medical practitioners who advertise cosmetic surgery, Australian Health Practitioner Regulation Agency. Available at: https://www.medicalboard.gov.au/Codes-Guidelines-Policies/Guidelines-for-registered-medical-practitioners-who-advertise-cosmetic-surgery.aspx
  7. Australian Competition and Consumer Commission (ACCC) 2021, A guide to advertising and selling for business, Australian Government. Available at: https://www.accc.gov.au/system/files/Advertising%20and%20selling%20guide%20-%20July%202021.pdf
  8. Australian Competition and Consumer Commission (ACCC) 2025, Advertising and promotions, Australian Government. Available at: https://www.accc.gov.au/business/advertising-and-promotions
  9. Papakonstantinou, E, Roth, M & Karakiulakis, G 2012, Hyaluronic acid: A key molecule in skin aging, Dermato-Endocrinology, vol. 4, no. 3, pp. 253–258. Available at: https://pubmed.ncbi.nlm.nih.gov/23467280/
  10. Bukhari, SNA, Roswandi, NL, Waqas, M et al. 2018, Hyaluronic acid, a promising skin rejuvenating biomedicine: a review of recent updates and pre-clinical and clinical investigations, Journal of Drug Delivery Science and Technology. Available at: https://pubmed.ncbi.nlm.nih.gov/30287361/
  11. Draelos, ZD 2021, Efficacy evaluation of a topical hyaluronic acid serum in facial photoaging, Clinical, Cosmetic and Investigational Dermatology, vol. 14, pp. 1325–1332. Available at: https://pubmed.ncbi.nlm.nih.gov/34176098/
  12. Rawlings, AV 2004, Moisturization and skin barrier function, Skin Pharmacology and Physiology, vol. 17, no. 6, pp. 253–267. Available at: https://pubmed.ncbi.nlm.nih.gov/14728698/
  13. Harwood, A & co-authors 2024, Moisturizers, StatPearls, NCBI Bookshelf. Available at: https://www.ncbi.nlm.nih.gov/books/NBK545171/
  14. Mawazi, SM, Hannan, MA & co-authors 2022, A review of moisturizers: history, preparation and classification, Cosmetics, vol. 9, no. 3, article 61. Available at: https://www.mdpi.com/2079-9284/9/3/61
  15. Australasian College of Dermatologists 2017, Xerosis (dry skin), A-Z of Skin, ACD, Sydney. Available at: https://www.dermcoll.edu.au/atoz/xerosis/
  16. Juncan, AM, Moisă, DG, Santini, A et al. 2021, Advantages of hyaluronic acid and its combination with other bioactive ingredients in cosmeceuticals, Molecules, vol. 26, no. 15, 4429. Available at: https://www.mdpi.com/1420-3049/26/15/4429
  17. Romanowitz, D 2024, Evaluation of antioxidants’ ability to enhance hyaluronic acid formulations, SKIN: The Journal of Cutaneous Medicine, vol. 8, no. 5. Available at: https://skin.dermsquared.com/skin/article/view/2554
  18. ABC Health & Wellbeing 2018, Moisturiser and dry skin: what works and what you need to know, Australian Broadcasting Corporation. Available at: https://www.abc.net.au/news/health/2018-03-06/what-you-need-to-know-about-moisturiser/9512528
  19. Sky Blue Dermatology 2014, Choosing a skin moisturiser, Sydney, NSW. Available at: https://www.skyblue.com.au/choosing-a-skin-moisturiser/

Newcastle Cosmetic Doctor

The clinic for everybody.

Opening Hours

envelopemap-markersmartphone